References
Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020;101:138–48. https://doi.org/10.1016/j.ijid.2020.09.1464.
A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020;20:e192-e197. https://doi.org/10.1016/S1473-3099(20)30483-7
Shah N, Dahi PB, Ponce DM, Sauter CS, Shaffer BC, Chung DJ, et al. Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection. Transpl Cell Ther. 2022;28:55.e1–55.e5. https://doi.org/10.1016/j.jtct.2021.10.004.
Christopeit M, Reichard M, Niederwieser C, Massoud R, Klyuchnikov E, Haase N, et al. Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection. Bone Marrow Transpl. 2021;56:1478–81. https://doi.org/10.1038/s41409-021-01225-w.
Niederwieser C, Weber B, Reichard M, Gagelmann N, Ajib S, Schlipfenbacher V, et al. Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19. Bone Marrow Transpl. 2022;57:1180–2. https://doi.org/10.1038/s41409-022-01660-3.
Author information
Authors and Affiliations
Contributions
AM contributed to analyzing data, interpreting results, and writing the report. JR contributed by writing the report, interpreting results, and editing. FK, ES, RC, and RFC contributed by designing the research protocol and editing the manuscript. RS contributed with statistical and data analysis. TS, AA, GR, JC, CL, MD, GC, DM, KR contributed by reviewing and giving feedback on the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Marinos, A., Ramdial, J., Khawaja, F. et al. Hematopoietic cell transplantation can be safely performed after COVID-19. Bone Marrow Transplant 58, 1410–1412 (2023). https://doi.org/10.1038/s41409-023-02105-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-023-02105-1
- Springer Nature Limited